- Strong match: 3 shared modalities
- Strong match: 3 shared learner audiences
- Also shares: advanced level
- Also shares: hybrid delivery
Back to StakeholdersHarvard University Innate Path Psychedelic Somatic Institute University of Ottowa
Categories
2 domains / 4 areas / 3 specializations
University of Wisconsin-Madison
Data updated
United States
10 Trials
The University of Wisconsin-Madison Transdisciplinary Center for Research in Psychoactive Substances is dedicated to exploring the scientific, historical, and cultural aspects of psychoactive substances, focusing on psychedelics.
AdvancedHybridPremiumAcademic programmeContinuing educationOtherResearchersLicensed cliniciansAspiring practitionersOther
Blossom’s read
UW-Madison looks like one of the more academically grounded entries in this space, with a proper university home rather than a stand-alone retreat brand. Its strength is breadth: science, history, law, ethics and clinical context, with faculty-linked research activity and pathways that suit people wanting serious, structured study rather than vibes-first training. It is probably best viewed as a research-led, institutionally credible option for those aiming at psychedelic science, regulated clinical work, or adjacent scholarship, rather than a facilitator school in the commercial sense.
Who University of Wisconsin-Madison is for
Best suited to recent graduates and working professionals who want a university-based route into psychedelic and psychoactive-substance science, development, history and clinical application. It also appears relevant for clinicians, researchers and people in related fields who want structured academic grounding rather than a purely practice-oriented course.
Prerequisites
For the MS, applicants need a bachelor’s degree, PharmD or equivalent from an accredited institution, a minimum undergraduate GPA of 3.0, and a background in physical or biological sciences, engineering, pharmacy, medicine, nursing, psychology, bioethics, law, history or a related field. The programme also expects completion of at least three college-level science courses totalling 9 or more credit hours. The capstone certificate is a University Special student route and is described as a rapid, non-degree alternative to the MS.
Accreditation & recognition
UW-Madison describes the MS in Psychoactive Pharmaceutical Investigation as the first accredited degree focusing on the study and therapeutic application of psychedelic compounds and related psychoactive drugs. The capstone certificate is a graduate-level certificate, but no independent professional licensure or external certification is stated on the sources reviewed. The continuing education symposium offers UW-Madison continuing education hours, but that is separate from the degree and capstone routes.
Cost
The MS programme page lists tuition at $1,500 per credit and 30 graduate credits in total, so the published tuition framing is clear, though fees and any separate costs are not detailed there. The centre notes that scholarships are available for MS students, including support for underrepresented backgrounds. I did not find a published cost for the capstone certificate in the sources reviewed.
What you walk away with
Learners can walk away with a Master of Science in Pharmaceutical Sciences, Psychoactive Pharmaceutical Investigation, or with a graduate capstone certificate in Psychoactive Pharmaceutical Investigation. The programme is framed around competence in psychedelic drug discovery, development, clinical application, legal regulation, and cross-disciplinary understanding spanning science and humanities.
Academic Research
0 papersPublished Papers
0
Trial Involvement
10
Distinct Focus Topics
0
Latest Publication
Unknown
Government funding received
1 grantARPA-H EVIDENT — Conscious vs non-conscious mechanisms of psilocybin therapy
2025
Part of the ARPA-H EVIDENT Initiative (total $139.4M, ≥$50M earmarked for psychedelic research for serious mental illness). UW-Madison contributes data from 3 approved psilocybin trials to dissociate the contributions of conscious psychedelic experience and non-conscious neurobiological mechanisms. Amount is an editorial estimate — funder has not published per-team award amounts; TO BE CONFIRMED.
SourceSimilar course providers
Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.
- Strong match: 2 shared modalities
- Strong match: 3 shared learner audiences
- Also shares: advanced level
- Also shares: hybrid delivery
- Strong match: 2 shared modalities
- Strong match: 2 shared learner audiences
- Also shares: advanced level
- Also shares: hybrid delivery
- Strong match: 2 shared modalities
- Strong match: 3 shared learner audiences
- Also shares: advanced level
- Also shares: hybrid delivery
Quick Facts
- Type
- academic
- HQ
- United States
- Website
- Visit